Colgate-Palmolive Company $CL Stock Sold by Inscription Capital LLC

Key Points

• Inscription Capital cut its Colgate-Palmolive stake by 69.5% in the third quarter, selling 33,947 shares and retaining 14,903 shares valued at about $1.27 million.
• Analyst sentiment was broadly positive: the stock has a “Moderate Buy” consensus and an average price target of $101.22, with several firms raising targets and JPMorgan lowering its target to $102.
• Colgate-Palmolive beat quarterly earnings and revenue estimates, reporting EPS of $0.97 and revenue of $5.37 billion; it also declared a $0.53 quarterly dividend.

Inscription Capital LLC reduced its stake in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 69.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,903 shares of the company's stock after selling 33,947 shares during the quarter. Inscription Capital LLC's holdings in Colgate-Palmolive were worth $1,271,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the business. Cooper Financial Group boosted its holdings in Colgate-Palmolive by 4.0% in the second quarter. Cooper Financial Group now owns 2,947 shares of the company's stock valued at $270,000 after purchasing an additional 114 shares during the last quarter. Gould Capital LLC boosted its stake in shares of Colgate-Palmolive by 38.7% in the first quarter. Gould Capital LLC now owns 412 shares of the company's stock worth $35,000 after buying an additional 115 shares during the last quarter. Redhawk Wealth Advisors Inc. grew its holdings in Colgate-Palmolive by 2.8% during the second quarter. Redhawk Wealth Advisors Inc. now owns 4,326 shares of the company's stock worth $397,000 after acquiring an additional 118 shares during the period. SVB Wealth LLC grew its holdings in Colgate-Palmolive by 1.4% during the second quarter. SVB Wealth LLC now owns 8,767 shares of the company's stock worth $804,000 after acquiring an additional 119 shares during the period. Finally, Sowell Financial Services LLC raised its position in Colgate-Palmolive by 2.1% during the third quarter. Sowell Financial Services LLC now owns 5,737 shares of the company's stock valued at $490,000 after acquiring an additional 119 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company's stock.

Analysts Set New Price Targets

CL has been the topic of a number of analyst reports. Morgan Stanley raised their price objective on shares of Colgate-Palmolive from $104.00 to $111.00 and gave the stock an "overweight" rating in a research note on Monday. JPMorgan Chase & Co. lowered their price target on shares of Colgate-Palmolive from $104.00 to $102.00 and set an "overweight" rating on the stock in a report on Monday. Royal Bank Of Canada increased their price target on shares of Colgate-Palmolive from $104.00 to $105.00 and gave the stock an "outperform" rating in a report on Monday. Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a $101.00 price target (up from $99.00) on shares of Colgate-Palmolive in a research report on Monday, August 3rd. Finally, Bank of America lifted their price objective on shares of Colgate-Palmolive from $100.00 to $105.00 and gave the company a "buy" rating in a report on Monday. Thirteen analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat, Colgate-Palmolive presently has an average rating of "Moderate Buy" and an average price target of $101.22.

Key Colgate-Palmolive News

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Several analysts raised their price targets, and BNP Paribas Exane reaffirmed its Outperform rating. The reports include updates from Read More., Read More., Read More., and Read More.. A separate report highlighted Morgan Stanley’s expectation for strong potential appreciation. Morgan Stanley report
• Positive Sentiment: Colgate-Palmolive’s defensive consumer-staples profile and dividend history may appeal to investors seeking reliable businesses amid political uncertainty. Its recent quarterly results also beat analyst estimates, as noted in the broader discussion of dividend stocks’ resilience. Dividend Kings article
• Neutral Sentiment: Analyst views are not uniformly bullish: Barclays maintained a Hold rating even as other coverage reported a target increase. This points to some optimism about upside but continued caution on valuation or near-term prospects. Barclays rating
• Negative Sentiment: Rising oil prices and cautious U.S. consumers are pressuring consumer-goods companies’ margins, a potential headwind for Colgate-Palmolive if costs rise faster than it can pass them through. Dividend-stock comparison
• Negative Sentiment: Colgate’s valuation may also weigh on the shares: a comparison with Hershey noted that Hershey trades at a lower forward P/E despite revenue growth, making CL look less attractive to valuation-focused investors. Colgate and Hershey comparison

Insiders Place Their Bets

In other Colgate-Palmolive news, COO Panagiotis Tsourapas sold 10,000 shares of the business's stock in a transaction on Monday, August 24th. The shares were sold at an average price of $92.05, for a total transaction of $920,500.00. Following the transaction, the chief operating officer directly owned 64,901 shares of the company's stock, valued at approximately $5,974,137.05. The trade was a 13.35% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.43% of the stock is currently owned by company insiders.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $98.68 on Friday. The company's fifty day moving average price is $90.01 and its 200 day moving average price is $89.92. Colgate-Palmolive Company has a 1 year low of $75.96 and a 1 year high of $101.18. The stock has a market capitalization of $78.44 billion, a P/E ratio of 25.45, a P/E/G ratio of 4.48 and a beta of 0.31. The company has a debt-to-equity ratio of 11.23, a quick ratio of 0.30 and a current ratio of 0.96.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings data on Friday, October 30th. The company reported $0.97 EPS for the quarter, beating the consensus estimate of $0.93 by $0.04. The firm had revenue of $5.37 billion during the quarter, compared to the consensus estimate of $5.34 billion. Colgate-Palmolive had a net margin of 9.65% and a return on equity of 607.88%. The company's quarterly revenue was up 4.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.91 earnings per share. As a group, equities research analysts anticipate that Colgate-Palmolive Company will post 3.91 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Tuesday, October 20th will be paid a $0.53 dividend. The ex-dividend date of this dividend is Tuesday, October 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.1%. Colgate-Palmolive's dividend payout ratio (DPR) is presently 83.14%.

Colgate-Palmolive Profile

Colgate-Palmolive Company NYSE: CL is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill's Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill's Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.